… in those with a history of narrow-angle glaucoma, of whom five also had transient angle
closure. Intraocular pressure changes and angle closure did not occur in patients receiving the …

… angle closure can be triggered by various classes of medications including adrenergic agonists,
… Ultimately, Coakes’ work suggests that exposure to β 2 -agonist alone will not cause an …

… Moreover, salbutamol, a β2 adrenoceptor agonist can compound the problem as it increases
aqueous humour production and thus acts synergistically with anti-muscarinic agents to …

… Adrenergic agonists Alpha-adrenergic agonists can precipitate acute angle closure glaucoma
by pupillary block due to pupil dilatation in individuals with innately narrow iridocorneal …

… acts as β 2 adrenoreceptor agonist. Unilateral or bilateral acute angle closure has been …
humor with its beta 2 adrenoreceptor agonist effect, thus contributing to angle closure [15]. …

%PURPOSE: To report acute angle-closure glaucoma associated with albuterol nebulizer
treatment. METHODS: Case report and review of the relevant literature. RESULTS: In a 75-…

… 2 -receptors is not as distinct as that found between α- and β-receptors, and there is … as
a β 1 -agonist or a β 2 -agonist. In addition a drug classified as a β 2 -agonist may lose its β 2 -…

… angle-closure glaucoma (PACG) is the leading cause of blindness in East Asia. The disease
can be classified into primary angle-closure suspect, primary angle closure … of angle closure…

… angles, such as those who are long-sighted. However, awareness should be raised to
identify secondary causes of angle closure, … Angle closure should be excluded in all patients …

… 30 days for prostaglandin analogs, 21 days for topical β-blockers, 14 days for adrenergic
agonists, and 5 days for cholinergic agonists and carbonic anhydrase inhibitors. At baseline, …